Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xian Zhang, Tong Wang, Yang Zhang, Fang Wang, Jiaqi Chen, Jingbo Ni, Ruijuan Sun, Zhijie Wei, Gailing Zhang, Wenqian Li, Jingjing Li & Peihua Lu. (2023) Characteristics and therapeutic approaches for patients diagnosed with T-ALL/LBL exhibiting t(8;14)(q24;q11)/TCRA/D:MYC translocation. Leukemia & Lymphoma 0:0, pages 1-7.
Read now
Read now
Articles from other publishers (30)
Marta Libura, Karolina Karabin, Paweł Tyrna, Anna Czyż, Hanna Makuch-Łasica, Bożena Jaźwiec, Monika Paluszewska, Beata Piątkowska-Jakubas, Magdalena Zawada, Michał Gniot, Joanna Trubicka, Magdalena Szymańska, Katarzyna Borg, Marta Więsik, Sylwia Czekalska, Izabela Florek, Maria Król, Małgorzata Paszkowska-Kowalewska, Lidia Gil, Katarzyna Kapelko-Słowik, Elżbieta Patkowska, Agnieszka Tomaszewska, Krzysztof Mądry, Rafał Machowicz, Tomasz Czerw, Agnieszka Piekarska, Magdalena Dutka, Anna Kopińska, Grzegorz Helbig, Tomasz Gromek, Krzysztof Lewandowski, Marta Zacharczuk, Anna Pastwińska, Tomasz Wróbel, Olga Haus, Grzegorz Basak, Jerzy Hołowiecki, Przemysław Juszczyński, Ewa Lech-Marańda, Sebastian Giebel & Wiesław Wiktor Jędrzejczak. (2023) Prognostic Impact of Copy Number Alterations’ Profile and AID/RAG Signatures in Acute Lymphoblastic Leukemia (ALL) with BCR::ABL and without Recurrent Genetic Aberrations (NEG ALL) Treated with Intensive Chemotherapy. Cancers 15:22, pages 5431.
Crossref
Crossref
Benjamin J. Lee, Shawn P. Griffin, Jean Doh, Alexandre Chan, Stefan O. Ciurea, Deepa Jeyakumar, Angela G. Fleischman, Kiran Naqvi, Nicholas R. Pannunzio, Susan O’Brien & Piyanuch Kongtim. (2023)
HyperCVAD
versus pegaspargase‐containing regimens for
Hispanic
adults with newly diagnosed
B
‐cell acute lymphoblastic leukemia
. European Journal of Haematology.
Crossref
Crossref
Pavla Taborska, Pavol Lukac, Dmitry Stakheev, Lenka Rajsiglova, Katerina Kalkusova, Karolina Strnadova, Lukas Lacina, Barbora Dvorankova, Jiri Novotny, Michal Kolar, Milena Vrana, Hana Cechova, Sarka Ransdorfova, Marie Valerianova, Karel SmetanaJrJr, Luca Vannucci & Daniel Smrz. (2023) Novel PD-L1- and collagen-expressing patient-derived cell line of undifferentiated pleomorphic sarcoma (JBT19) as a model for cancer immunotherapy. Scientific Reports 13:1.
Crossref
Crossref
Yang Ruan, Longlong Xie & Aijun Zou. (2023) Association of CDKN2A/B mutations, PD-1, and PD-L1 with the risk of acute lymphoblastic leukemia in children. Journal of Cancer Research and Clinical Oncology 149:12, pages 10841-10850.
Crossref
Crossref
Mirella Ampatzidou, Stefanos I. Papadhimitriou, Anna Paisiou, Georgios Paterakis, Marianna Tzanoudaki, Vassilios Papadakis, Lina Florentin & Sophia Polychronopoulou. (2023) The Prognostic Effect of CDKN2A/2B Gene Deletions in Pediatric Acute Lymphoblastic Leukemia (ALL): Independent Prognostic Significance in BFM-Based Protocols. Diagnostics 13:9, pages 1589.
Crossref
Crossref
钰 李. (2023) Molecular Characteristics and Clinical Significance of Acute B-Cell Acute Lymphoblastic Leukemia in Children. Advances in Clinical Medicine 13:04, pages 6469-6477.
Crossref
Crossref
Jumpei Ito, Kazutsune Yamagata, Haruka Shinohara, Yutaka Shima, Takuo Katsumoto, Yukiko Aikawa & Issay Kitabayashi. (2022) Dual inhibition of EZH1/2 induces cell cycle arrest of B cell acute lymphoblastic leukemia cells through upregulation of CDKN1C and TP53INP1. International Journal of Hematology 117:1, pages 78-89.
Crossref
Crossref
Sarita Kumari, Jay Singh, Mohit Arora, M. Shadab Ali, Avanish K Pandey, Mercilena Benjamin, Jayanth Kumar Palanichamy, Sameer Bakhshi, Imteyaz Qamar & Anita Chopra. (2022) Copy Number Alterations in CDKN2A/2B and MTAP Genes Are Associated With Low MEF2C Expression in T-cell Acute Lymphoblastic Leukemia. Cureus.
Crossref
Crossref
Margherita Rimini, Carles Fabregat-Franco, Valentina Burgio, Sara Lonardi, Monica Niger, Mario Scartozzi, Ilario Giovanni Rapposelli, Giuseppe Aprile, Francesca Ratti, Federica Pedica, Helena Verdaguer, Mario Rizzato, Federico Nichetti, Eleonora Lai, Alessandro Cappetta, Teresa Macarulla, Matteo Fassan, Filippo De Braud, Andrea Pretta, Francesca Simionato, Francesco De Cobelli, Luca Aldrighetti, Lorenzo Fornaro, Stefano Cascinu & Andrea Casadei-Gardini. (2022) Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma. Scientific Reports 12:1.
Crossref
Crossref
Shlomo Tsuriel, Victoria Hannes, Asala Hasona, Michal Raz & Dov Hershkovitz. (2022) Digital PCR-Based Method for Detecting CDKN2A Loss in Brain Tumours. Molecular Diagnosis & Therapy 26:6, pages 689-698.
Crossref
Crossref
Alessia Schirripa, Veronika Sexl & Karoline Kollmann. (2022) Cyclin-dependent kinase inhibitors in malignant hematopoiesis. Frontiers in Oncology 12.
Crossref
Crossref
Charlotte EJ. Downes, Barbara J. McClure, Daniel P. McDougal, Susan L. Heatley, John B. Bruning, Daniel Thomas, David T. Yeung & Deborah L. White. (2022) JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Bengisu GÖKKAYA, Sezen ATASOY, Ayşe ÇIRAKOĞLU, Yelda TARKAN ARGÜDEN, R. Dilhan KURU, Şükriye YILMAZ, Şeniz ÖNGÖREN & Ayhan DEVİREN. (2022) A Preliminary Investigation on the Chromosome Aberrations in Acute Lymphoblastic Leukaemia Using Multiprobe Fluorescence In Situ Hybridization Panel. Bezmialem Science 10:3, pages 370-375.
Crossref
Crossref
Yinghuan Dai, Ping Liu, Wenlong He, Lizhen Yang, Yang Ni, Xuejiao Ma, Furong Du, Chao Song, Yang Liu & Yi Sun. (2022) Genomic Features of Solid Tumor Patients Harboring ALK/ROS1/NTRK Gene Fusions. Frontiers in Oncology 12.
Crossref
Crossref
Víctor Galán-Gómez, Nerea Matamala, Beatriz Ruz-Caracuel, Paula Valle-Simón, Bárbara Ochoa-Fernández, Pilar Guerra-García, Alicia Pernas-Sánchez, Jordi Minguillón, Berta González, Isabel Martínez-Romera, Sonsoles Román-Pacheco, Pablo Estival-Monteliú, Adrián Ibáñez-Navarro, Antonio Pérez-Martínez & Adela Escudero-López. (2022) Advanced Molecular Characterisation in Relapsed and Refractory Paediatric Acute Leukaemia, the Key for Personalised Medicine. Journal of Personalized Medicine 12:6, pages 881.
Crossref
Crossref
Yishai Ofran & Jacob M. Rowe. (2022) Cytogenetics or MRD in B-cell ALL. Do both reign supreme?. Leukemia 36:5, pages 1201-1202.
Crossref
Crossref
Monika Lejman, Aleksandra Chałupnik, Zuzanna Chilimoniuk & Maciej Dobosz. (2022) Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children. International Journal of Molecular Sciences 23:5, pages 2755.
Crossref
Crossref
Cindy Martinez, Luz Karime Yunis, Edgar Cabrera, Johnny García, Gloria Uribe, Edna Quintero, Juan Jose Yunis, Adriana Linares Ballesteros & Isabel Cristina Sarmiento. (2022) Association between early risk factors and CDKN2A/B deletion in pediatric patients with acute lymphoblastic leukemia in a pediatric cancer center in Colombia. Pediatric Hematology Oncology Journal 7:1, pages 1-3.
Crossref
Crossref
Tomas Arpas, Hana Jelinkova, Stepan Hrabovsky, Martina Orsulova, Zuzana Vrzalova, Veronika Navrkalova, Eva Brhelova, Lenka Bryjova, Alena Bulikova, Eva Ondrouskova, Marketa Sejnohova, Frantisek Folber, Petra Sedová, Jiri Mayer, Sarka Pospisilova, Marie Jarosova & Michael Doubek. (2022) Very rare near‐haploid acute lymphoblastic leukemia resistant to immunotherapy and CAR‐T therapy in 19‐year‐old male patient. Clinical Case Reports 10:3.
Crossref
Crossref
Sunil S. Raikar, David T. Teachey & Nathan P. Gossai. 2022. Clinical Management of Acute Lymphoblastic Leukemia. Clinical Management of Acute Lymphoblastic Leukemia
329
351
.
Karen L. Bride, Hai Hu, Anastasia Tikhonova, Tori J. Fuller, Tiffaney L. Vincent, Rawan Shraim, Marilyn M. Li, William L. Carroll, Elizabeth A. Raetz, Iannis Aifantis & David T. Teachey. (2021) Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic leukemia. Haematologica 107:8, pages 1746-1757.
Crossref
Crossref
Klementina Crepinsek, Gasper Marinsek, Marko Kavcic, Tomaž Prelog, Lidija Kitanovski, Janez Jazbec & Marusa Debeljak. (2021) Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience. Radiology and Oncology 56:1, pages 92-101.
Crossref
Crossref
Wencke Walter, Rabia Shahswar, Anna Stengel, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach & Claudia Haferlach. (2021) Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia. BMC Cancer 21:1.
Crossref
Crossref
Μirella Αmpatzidou, Lina Florentin, Vassilios Papadakis, Georgios Paterakis, Marianna Tzanoudaki, Dimitra Bouzarelou, Stefanos I. Papadhimitriou & Sophia Polychronopoulou. (2021) Copy Number Alteration Profile Provides Additional Prognostic Value for Acute Lymphoblastic Leukemia Patients Treated on BFM Protocols. Cancers 13:13, pages 3289.
Crossref
Crossref
Anissa Lahfafa, Maëlle de Ville de Goyet, Cécile Boulanger, Jean-Philippe Defour, Thierry Detaille, An Van Damme & Bénédicte Brichard. (2021) B-acute Lymphoblastic Leukemia With Hypereosinophilia Associated With Severe Cardiac Complications: A Clinical Case. Journal of Pediatric Hematology/Oncology 43:1, pages e51-e55.
Crossref
Crossref
Yao Li, Zuo-Xin Zhang, Guo-Hao Huang, Yan Xiang, Lin Yang, Yu-Chun Pei, Wei Yang & Sheng-Qing Lv. (2021) A systematic review of multifocal and multicentric glioblastoma. Journal of Clinical Neuroscience 83, pages 71-76.
Crossref
Crossref
Beatriz Rosales-Rodríguez, Juan Carlos Núñez-Enríquez, Juan Manuel Mejía-Aranguré & Haydeé Rosas-Vargas. (2020) Prognostic Impact of Somatic Copy Number Alterations in Childhood B-Lineage Acute Lymphoblastic Leukemia. Current Oncology Reports 23:1.
Crossref
Crossref
Wanhua Zhang, Pu Kuang & Ting Liu. (2020) Role of BCR-ABL1 isoforms on the prognosis of Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A meta-analysis. PLOS ONE 15:12, pages e0243657.
Crossref
Crossref
Adrián Montaño, Jesús Hernández-Sánchez, Maribel Forero-Castro, María Matorra-Miguel, Eva Lumbreras, Cristina Miguel, Sandra Santos, Valentina Ramírez-Maldonado, José Luís Fuster, Natalia de Las Heras, Alfonso García-de Coca, Magdalena Sierra, Julio Dávila, Ignacio de la Fuente, Carmen Olivier, Juan Olazabal, Joaquín Martínez, Nerea Vega-García, Teresa González, Jesús María Hernández-Rivas & Rocío Benito. (2020) Comprehensive Custom NGS Panel Validation for the Improvement of the Stratification of B-Acute Lymphoblastic Leukemia Patients. Journal of Personalized Medicine 10:3, pages 137.
Crossref
Crossref
Miller, Park, Saxe, Lew & Raikar. (2019) Clonal Evolution of B-Cell Acute Lymphoblastic Leukemia with del(9)(p13p21) into Mixed Phenotype Acute Leukemia Presenting as an Isolated Testicular Relapse. Reports 2:3, pages 18.
Crossref
Crossref